Tasso, Inc.

United States - Seattle, Washington

• 16/12/2021
• Series B
• $100,000,000

Tasso is a fast-growing Seattle-based startup focused on delivering at-home diagnostic testing to those who need it most. We are growing our footprint with leading health systems, clinical research organizations, academic medical centers, and more who are looking to deliver clinical-grade, convenient diagnostic tests to their patients. Tasso was originally founded to find a better way to collect blood instead of a painful fingerstick or time-consuming venous draw. Since then, our products have been used in pharmaceutical clinical trials, by Olympians as part of a new virtual anti-doping program, and broadly by hospital systems across the US.

Related People

Erwin BerthierCo Founder

United States - Seattle, Washington,

My goal is to develop better diagnostics that integrate seamlessly into our livestyles and improve health and quality of life. I value elegant and simple solutions that need as little engineering as possible and enable affordable and user-centric technologies. I have led multiple academic research, translational, and industry projects in areas of diagnostics, medical devices, and medical microbiology.

LinkedIn https://www.linkedin.com/in/erwin-berthier-98b94036/